Clinical trial of ghrelin administration in patients with chronic obstructive pulmonary disease
Not Applicable
- Conditions
- Chronic obstructive pulmonary disease
- Registration Number
- JPRN-C000000061
- Lead Sponsor
- ational Cardiovascular Center Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with malignant tumors Patients with active infection Patients with severe heart disease Patients with hepatic failure (serum levels of AST and ALT greater than twice the normal upper limit) Patients with renal failure (serum creatinine concentration >= 2.0 mg/dL) Patients with asthma Patients who are or could be pregnant Patients whose drug regimen was changed within one month before participation in this study In addition to the above exclusion criteria, patients judged to be inadequate to participate in this study by their physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method QOL score (SGRQ) Six-minute walk distance
- Secondary Outcome Measures
Name Time Method QOL score (SF-36) Medical Research Council (MRC) dyspnea scale Food intake Vital capacity (VC) FEV1% Maximal inspiratory pressure Maximal expiratory pressure Plasma norepinephrine level Peak oxygen uptake